May 28 (Reuters) - Neurocrine Biosciences said on Tuesday Kevin Gorman would retire as chief executive officer on Oct. 11 and will be succeeded by Kyle Gano. (Reporting by Sneha S K in Bengaluru; Editing by Maju Samuel)